Global Orphan Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 18-Jun-2019
No. of pages: 120
Inquire Before Buying

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.

High unmet needs are one of the primary drivers of market growth. The need for the development of effective drugs with lesser side-effects is rapidly rising in the market.

Moreover, the initiatives from the governments of various countries across the globe towards R&D activities and numerous marketing approvals of these drugs have also influenced the orphan drugs market growth. Furthermore, the rising occurrences of rare diseases with the mounting awareness among the population and larger life expectancy numbers have accelerated the global orphan drug market to grow higher.

The global Orphan Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orphan Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Orphan Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Orphan Drugs in these regions.

This research report categorizes the global Orphan Drugs market by top players/brands, region, type and end user. This report also studies the global Orphan Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Novartis

- Bristol-Myers Squibb

- Celgene

- Roche

- Pfizer

- Sanofi

- Alexion Pharmaceuticals

- Eli Lilly

- Novo Nordisk

- AstraZeneca

- Eisai

- Daiichi Sankyo

- Bayer

- GlaxoSmithKline

- Merck

- Johnson & Johnson

- Biogen

- Shire

- Amgen

Market size by Product

- Oncology

- Gastrointestinal

- Pulmonary

- Neurology

- Hematology

- Cardio-vascular

- Metabolic disorders

- Endocrinology

- Infectious diseases

- Others

Market size by End User

- Hospital Pharmacies

- Speciality Pharmacies

- Retail pharmacies

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Orphan Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Orphan Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Orphan Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Orphan Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Orphan Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orphan Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Orphan Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Orphan Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Orphan Drugs Market Size Growth Rate by Product
1.4.2 Oncology
1.4.3 Gastrointestinal
1.4.4 Pulmonary
1.4.5 Neurology
1.4.6 Hematology
1.4.7 Cardio-vascular
1.4.8 Metabolic disorders
1.4.9 Endocrinology
1.4.10 Infectious diseases
1.4.11 Others
1.5 Market by End User
1.5.1 Global Orphan Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Speciality Pharmacies
1.5.4 Retail pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Orphan Drugs Market Size
2.1.1 Global Orphan Drugs Revenue 2014-2025
2.1.2 Global Orphan Drugs Sales 2014-2025
2.2 Orphan Drugs Growth Rate by Regions
2.2.1 Global Orphan Drugs Sales by Regions
2.2.2 Global Orphan Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Orphan Drugs Sales by Manufacturers
3.1.1 Orphan Drugs Sales by Manufacturers
3.1.2 Orphan Drugs Sales Market Share by Manufacturers
3.1.3 Global Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Orphan Drugs Revenue by Manufacturers
3.2.1 Orphan Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Orphan Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Orphan Drugs Price by Manufacturers
3.4 Orphan Drugs Manufacturing Base Distribution, Product Types
3.4.1 Orphan Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orphan Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Orphan Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Orphan Drugs Sales by Product
4.2 Global Orphan Drugs Revenue by Product
4.3 Orphan Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Orphan Drugs Breakdown Data by End User
6 North America
6.1 North America Orphan Drugs by Countries
6.1.1 North America Orphan Drugs Sales by Countries
6.1.2 North America Orphan Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Orphan Drugs by Product
6.3 North America Orphan Drugs by End User
7 Europe
7.1 Europe Orphan Drugs by Countries
7.1.1 Europe Orphan Drugs Sales by Countries
7.1.2 Europe Orphan Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orphan Drugs by Product
7.3 Europe Orphan Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Orphan Drugs by Countries
8.1.1 Asia Pacific Orphan Drugs Sales by Countries
8.1.2 Asia Pacific Orphan Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Orphan Drugs by Product
8.3 Asia Pacific Orphan Drugs by End User
9 Central & South America
9.1 Central & South America Orphan Drugs by Countries
9.1.1 Central & South America Orphan Drugs Sales by Countries
9.1.2 Central & South America Orphan Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Orphan Drugs by Product
9.3 Central & South America Orphan Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Orphan Drugs by Countries
10.1.1 Middle East and Africa Orphan Drugs Sales by Countries
10.1.2 Middle East and Africa Orphan Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Orphan Drugs by Product
10.3 Middle East and Africa Orphan Drugs by End User
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Orphan Drugs Products Offered
11.1.5 Novartis Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Company Business Overview
11.2.3 Bristol-Myers Squibb Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bristol-Myers Squibb Orphan Drugs Products Offered
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Company Business Overview
11.3.3 Celgene Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Celgene Orphan Drugs Products Offered
11.3.5 Celgene Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Company Business Overview
11.4.3 Roche Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Roche Orphan Drugs Products Offered
11.4.5 Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Orphan Drugs Products Offered
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Sanofi Orphan Drugs Products Offered
11.6.5 Sanofi Recent Development
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Alexion Pharmaceuticals Orphan Drugs Products Offered
11.7.5 Alexion Pharmaceuticals Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Company Business Overview
11.8.3 Eli Lilly Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Eli Lilly Orphan Drugs Products Offered
11.8.5 Eli Lilly Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Company Business Overview
11.9.3 Novo Nordisk Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Novo Nordisk Orphan Drugs Products Offered
11.9.5 Novo Nordisk Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 Company Business Overview
11.10.3 AstraZeneca Orphan Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AstraZeneca Orphan Drugs Products Offered
11.10.5 AstraZeneca Recent Development
11.11 Eisai
11.12 Daiichi Sankyo
11.13 Bayer
11.14 GlaxoSmithKline
11.15 Merck
11.16 Johnson & Johnson
11.17 Biogen
11.18 Shire
11.19 Amgen
12 Future Forecast
12.1 Orphan Drugs Market Forecast by Regions
12.1.1 Global Orphan Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Orphan Drugs Revenue Forecast by Regions 2019-2025
12.2 Orphan Drugs Market Forecast by Product
12.2.1 Global Orphan Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Orphan Drugs Revenue Forecast by Product 2019-2025
12.3 Orphan Drugs Market Forecast by End User
12.4 North America Orphan Drugs Forecast
12.5 Europe Orphan Drugs Forecast
12.6 Asia Pacific Orphan Drugs Forecast
12.7 Central & South America Orphan Drugs Forecast
12.8 Middle East and Africa Orphan Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orphan Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Orphan Drugs Product Picture
Table Orphan Drugs Market Segments
Table Key Manufacturers Orphan Drugs Covered
Table Global Orphan Drugs Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Orphan Drugs Sales Market Share by Product 2014-2025
Figure Oncology Product Picture
Table Major Manufacturers of Oncology
Figure Gastrointestinal Product Picture
Table Major Manufacturers of Gastrointestinal
Figure Pulmonary Product Picture
Table Major Manufacturers of Pulmonary
Figure Neurology Product Picture
Table Major Manufacturers of Neurology
Figure Hematology Product Picture
Table Major Manufacturers of Hematology
Figure Cardio-vascular Product Picture
Table Major Manufacturers of Cardio-vascular
Figure Metabolic disorders Product Picture
Table Major Manufacturers of Metabolic disorders
Figure Endocrinology Product Picture
Table Major Manufacturers of Endocrinology
Figure Infectious diseases Product Picture
Table Major Manufacturers of Infectious diseases
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Orphan Drugs Market Size Growth Rate by End User 2019-2025 (MT)
Figure Hospital Pharmacies
Figure Speciality Pharmacies
Figure Retail pharmacies
Figure Others
Figure Orphan Drugs Report Years Considered
Figure Global Orphan Drugs Market Size 2014-2025 (Million US$)
Figure Global Orphan Drugs Sales 2014-2025 (MT)
Table Global Orphan Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Orphan Drugs Sales by Regions 2014-2019 (MT)
Table Global Orphan Drugs Sales Market Share by Regions 2014-2019
Figure Global Orphan Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Orphan Drugs Sales Market Share by Regions
Table Global Orphan Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Orphan Drugs Revenue Market Share by Regions 2014-2019
Figure Global Orphan Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Orphan Drugs Revenue Market Share by Regions
Table Global Orphan Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Orphan Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Orphan Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Orphan Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Orphan Drugs Revenue Share by Manufacturers (2014-2019)
Figure Orphan Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Orphan Drugs Price (2014-2019) (USD/Kg)
Table Orphan Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Orphan Drugs Product Type
Table Date of International Manufacturers Enter into Orphan Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Orphan Drugs Sales by Product (2014-2019) (MT)
Table Global Orphan Drugs Sales Share by Product (2014-2019)
Figure Global Orphan Drugs Sales Market Share by Product (2014-2019)
Figure Global Orphan Drugs Sales Market Share by Product in 2018
Table Global Orphan Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Orphan Drugs Revenue Share by Product (2014-2019)
Figure Global Orphan Drugs Revenue Market Share by Product (2014-2019)
Figure Global Orphan Drugs Revenue Market Share by Product in 2018
Table Orphan Drugs Price by Product 2014-2019 (USD/Kg)
Table Global Orphan Drugs Sales by End User (2014-2019) (MT)
Table Global Orphan Drugs Sales Share by End User (2014-2019)
Figure Global Sales Orphan Drugs Market Share by End User (2014-2019)
Figure Global Sales Orphan Drugs Market Share by End User in 2018
Figure North America Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Orphan Drugs Sales by Countries (2014-2019) (MT)
Table North America Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Orphan Drugs Sales Market Share by Countries
Table North America Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Orphan Drugs Revenue Market Share by Countries
Figure United States Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure United States Orphan Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Canada Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Orphan Drugs Sales by Product (2014-2019) (MT)
Table North America Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Orphan Drugs Market Share by Product
Table North America Orphan Drugs Sales by End User (2014-2019) (MT)
Table North America Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Orphan Drugs Market Share by End User
Figure Europe Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Europe Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Orphan Drugs Sales Market Share by Countries
Table Europe Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Orphan Drugs Revenue Market Share by Countries
Figure Germany Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Germany Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Orphan Drugs Sales by Product (2014-2019) (MT)
Table Europe Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Orphan Drugs Market Share by Product
Table Europe Orphan Drugs Sales by End User (2014-2019) (MT)
Table Europe Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Orphan Drugs Market Share by End User
Figure Asia Pacific Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Sales Market Share by Countries
Table Asia Pacific Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Revenue Market Share by Countries
Figure China Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Singapore Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Orphan Drugs Sales by Product (2014-2019) (MT)
Table Asia Pacific Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Market Share by Product
Table Asia Pacific Orphan Drugs Sales by End User (2014-2019) (MT)
Table Asia Pacific Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Orphan Drugs Market Share by End User
Figure Central & South America Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Orphan Drugs Sales Market Share by Countries
Table Central & South America Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Orphan Drugs Revenue Market Share by Countries
Figure Brazil Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Argentina Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Orphan Drugs Sales by Product (2014-2019) (MT)
Table Central & South America Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Orphan Drugs Market Share by Product
Table Central & South America Orphan Drugs Sales by End User (2014-2019) (MT)
Table Central & South America Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Orphan Drugs Market Share by End User
Figure Middle East and Africa Orphan Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Orphan Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Orphan Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Orphan Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Sales Market Share by Countries
Table Middle East and Africa Orphan Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Orphan Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Revenue Market Share by Countries
Figure GCC Countries Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Turkey Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Orphan Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Orphan Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Orphan Drugs Sales by Product (2014-2019) (MT)
Table Middle East and Africa Orphan Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Market Share by Product
Table Middle East and Africa Orphan Drugs Sales by End User (2014-2019) (MT)
Table Middle East and Africa Orphan Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Orphan Drugs Market Share by End User
Table Novartis Company Details
Table Novartis Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celgene Company Details
Table Celgene Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Celgene Recent Development
Table Roche Company Details
Table Roche Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Alexion Pharmaceuticals Company Details
Table Alexion Pharmaceuticals Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Alexion Pharmaceuticals Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novo Nordisk Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Orphan Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Eisai Company Details
Table Daiichi Sankyo Company Details
Table Bayer Company Details
Table GlaxoSmithKline Company Details
Table Merck Company Details
Table Johnson & Johnson Company Details
Table Biogen Company Details
Table Shire Company Details
Table Amgen Company Details
Table Global Orphan Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Global Orphan Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Orphan Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Orphan Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Orphan Drugs Sales Forecast by Product 2019-2025 (MT)
Table Global Orphan Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Orphan Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Orphan Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Orphan Drugs Sales Forecast by End User 2019-2025 (MT)
Table Global Orphan Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Orphan Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Orphan Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Orphan Drugs Value Chain
Table Orphan Drugs Customers List
Table Orphan Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Travel Vaccines Market Insights, Forecast to 2025
    Published: 22-Jul-2019        Price: US 3900 Onwards        Pages: 114
    Exposure to new environments and diseases can put travellers at an increased risk of serious illness. Travel vaccines against diseases such as hepatitis A and B, rabies, typhoid and cholera The global Travel Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Travel Vaccines market based on company, product type, end ......
  • Global Hyoscine-N-Butyl Bromide Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 21-Jul-2019        Price: US 3000 Onwards        Pages: 99
    Summary The report forecast global Hyoscine-N-Butyl Bromide market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Hyoscine-N-Butyl Bromide industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hyoscine-N-Butyl Bromide by geography. The report splits the market size, ......
  • Global Inhalation & Nasal Spray Generic Drugs Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 21-Jul-2019        Price: US 3000 Onwards        Pages: 106
    Summary Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA, A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.Inhalation & Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caus......
  • Global Lactulose Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 21-Jul-2019        Price: US 3000 Onwards        Pages: 91
    Summary Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. The report forecast global Lactulose market to grow to reach xxx Million USD in ......
  • Global Nicotine Gum Market Research Report 2012-2024
    Published: 21-Jul-2019        Price: US 1960 Onwards        Pages: 69
    Summary Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. It is one of nicotine replacement therapies (NRT's) and it is an over-the-counter medication. The global Nicotine Gum market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The obj......
  • Global Nasal Drops Market Research Report 2012-2024
    Published: 21-Jul-2019        Price: US 2690 Onwards        Pages: 84
    Summary The global Nasal Drops market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Global Legal Marijuana Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 20-Jul-2019        Price: US 3000 Onwards        Pages: 112
    Summary Marijuana is one of the most abused drugs in the world. And this report studies the Legal Marijuana. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time The r......
  • Global Medical Grade Hydrogel Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 20-Jul-2019        Price: US 3000 Onwards        Pages: 137
    Summary The report forecast global Medical Grade Hydrogel market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Medical Grade Hydrogel industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Medical Grade Hydrogel by geography. The report splits the market size, by vol......
  • Global Melatonin Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 20-Jul-2019        Price: US 3000 Onwards        Pages: 106
    Summary Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress. The report forecast global Melatonin market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024. The report offers detailed coverage of Melatonin industry a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs